Chemfab Alkalis Limited Logo

Chemfab Alkalis Limited

CHEMFAB.NS

(2.8)
Stock Price

985,55 INR

3.6% ROA

4.81% ROE

82.86x PER

Market Cap.

14.910.481.040,00 INR

4.81% DER

0.12% Yield

5.54% NPM

Chemfab Alkalis Limited Stock Analysis

Chemfab Alkalis Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Chemfab Alkalis Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (15.17%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a minimal amount of debt (3%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 PBV

The stock's PBV ratio (1.73x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

5 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

6 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

7 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-36), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Chemfab Alkalis Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Chemfab Alkalis Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Chemfab Alkalis Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Chemfab Alkalis Limited Revenue
Year Revenue Growth
2008 899.003.878
2009 872.874.978 -2.99%
2010 799.981.570 -9.11%
2011 765.172.620 -4.55%
2012 1.159.313.273 34%
2013 1.126.649.392 -2.9%
2014 1.103.908.164 -2.06%
2015 1.013.127.034 -8.96%
2016 1.404.330.809 27.86%
2017 1.840.255.000 23.69%
2018 1.930.892.000 4.69%
2019 2.041.894.000 5.44%
2020 1.805.823.000 -13.07%
2021 2.712.692.000 33.43%
2022 3.311.226.000 18.08%
2023 3.183.300.000 -4.02%
2023 3.272.968.000 2.74%
2024 3.061.244.000 -6.92%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Chemfab Alkalis Limited Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 6.443.000 100%
2017 5.607.000 -14.91%
2018 6.837.000 17.99%
2019 6.605.000 -3.51%
2020 6.319.000 -4.53%
2021 4.035.000 -56.6%
2022 6.553.000 38.43%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Chemfab Alkalis Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 19.966.603 100%
2016 26.206.112 23.81%
2017 19.100.000 -37.2%
2018 18.660.000 -2.36%
2019 19.295.000 3.29%
2020 25.205.000 23.45%
2021 24.043.000 -4.83%
2022 35.643.000 32.54%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Chemfab Alkalis Limited EBITDA
Year EBITDA Growth
2008 220.158.516
2009 183.888.091 -19.72%
2010 169.907.274 -8.23%
2011 172.885.032 1.72%
2012 390.062.984 55.68%
2013 279.983.555 -39.32%
2014 261.464.893 -7.08%
2015 293.162.296 10.81%
2016 349.939.593 16.22%
2017 523.863.000 33.2%
2018 621.297.000 15.68%
2019 580.800.000 -6.97%
2020 244.185.000 -137.85%
2021 628.127.000 61.12%
2022 1.097.269.000 42.76%
2023 493.524.000 -122.33%
2023 538.949.000 8.43%
2024 333.284.000 -61.71%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Chemfab Alkalis Limited Gross Profit
Year Gross Profit Growth
2008 459.061.175
2009 404.452.044 -13.5%
2010 360.625.225 -12.15%
2011 389.912.827 7.51%
2012 612.304.629 36.32%
2013 507.486.600 -20.65%
2014 476.198.159 -6.57%
2015 521.198.847 8.63%
2016 665.215.863 21.65%
2017 920.318.000 27.72%
2018 961.250.000 4.26%
2019 921.599.000 -4.3%
2020 604.569.000 -52.44%
2021 972.614.000 37.84%
2022 1.567.139.000 37.94%
2023 1.135.016.000 -38.07%
2023 712.493.000 -59.3%
2024 530.568.000 -34.29%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Chemfab Alkalis Limited Net Profit
Year Net Profit Growth
2008 78.401.708
2009 72.150.953 -8.66%
2010 96.747.265 25.42%
2011 74.741.796 -29.44%
2012 234.823.971 68.17%
2013 164.474.662 -42.77%
2014 102.269.705 -60.82%
2015 86.606.433 -18.09%
2016 154.747.676 44.03%
2017 254.745.000 39.25%
2018 167.558.000 -52.03%
2019 254.461.000 34.15%
2020 -81.315.000 412.93%
2021 287.468.000 128.29%
2022 645.833.000 55.49%
2023 172.124.000 -275.21%
2023 263.231.000 34.61%
2024 35.828.000 -634.71%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Chemfab Alkalis Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 9
2009 8 -14.29%
2010 11 30%
2011 8 -25%
2012 26 68%
2013 18 -47.06%
2014 11 -54.55%
2015 1 0%
2016 11 100%
2017 18 38.89%
2018 12 -50%
2019 18 33.33%
2020 -6 460%
2021 20 125%
2022 46 55.56%
2023 12 -275%
2023 19 33.33%
2024 3 -800%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Chemfab Alkalis Limited Free Cashflow
Year Free Cashflow Growth
2008 22.564.251
2009 80.775.643 72.07%
2010 59.746.096 -35.2%
2011 53.018.865 -12.69%
2012 129.261.644 58.98%
2013 -460.563.775 128.07%
2014 62.800.540 833.38%
2015 53.219.960 -18%
2016 299.390.475 82.22%
2017 184.359.000 -62.4%
2018 -120.405.000 253.12%
2019 -80.378.000 -49.8%
2020 380.962.000 121.1%
2021 347.135.000 -9.74%
2022 349.825.000 0.77%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Chemfab Alkalis Limited Operating Cashflow
Year Operating Cashflow Growth
2008 152.968.769
2009 177.802.070 13.97%
2010 100.610.257 -76.72%
2011 71.254.484 -41.2%
2012 311.152.853 77.1%
2013 162.549.895 -91.42%
2014 200.212.045 18.81%
2015 160.807.290 -24.5%
2016 379.094.327 57.58%
2017 445.955.000 14.99%
2018 409.937.000 -8.79%
2019 542.284.000 24.41%
2020 454.321.000 -19.36%
2021 549.102.000 17.26%
2022 925.947.000 40.7%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Chemfab Alkalis Limited Capital Expenditure
Year Capital Expenditure Growth
2008 130.404.518
2009 97.026.427 -34.4%
2010 40.864.161 -137.44%
2011 18.235.619 -124.09%
2012 181.891.209 89.97%
2013 623.113.670 70.81%
2014 137.411.505 -353.47%
2015 107.587.330 -27.72%
2016 79.703.852 -34.98%
2017 261.596.000 69.53%
2018 530.342.000 50.67%
2019 622.662.000 14.83%
2020 73.359.000 -748.79%
2021 201.967.000 63.68%
2022 576.122.000 64.94%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Chemfab Alkalis Limited Equity
Year Equity Growth
2008 688.507.692
2009 733.832.577 6.18%
2010 803.842.339 8.71%
2011 878.584.135 8.51%
2012 1.060.110.228 17.12%
2013 1.211.171.857 12.47%
2014 1.295.720.375 6.53%
2015 1.368.552.392 5.32%
2016 1.647.605.091 16.94%
2017 2.361.792.000 30.24%
2018 2.511.081.000 5.95%
2019 2.755.258.000 8.86%
2020 2.673.252.000 -3.07%
2021 2.980.018.000 10.29%
2022 3.613.544.000 17.53%
2023 3.872.648.000 6.69%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Chemfab Alkalis Limited Assets
Year Assets Growth
2008 1.078.418.084
2009 1.057.853.276 -1.94%
2010 1.031.001.865 -2.6%
2011 1.118.362.634 7.81%
2012 1.356.118.274 17.53%
2013 1.804.038.206 24.83%
2014 1.872.177.344 3.64%
2015 1.862.610.235 -0.51%
2016 2.160.775.097 13.8%
2017 2.981.697.000 27.53%
2018 3.209.913.000 7.11%
2019 3.483.664.000 7.86%
2020 3.349.247.000 -4.01%
2021 3.521.837.000 4.9%
2022 4.120.961.000 14.54%
2023 5.003.218.000 17.63%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Chemfab Alkalis Limited Liabilities
Year Liabilities Growth
2008 389.910.392
2009 324.020.699 -20.34%
2010 227.159.526 -42.64%
2011 239.778.499 5.26%
2012 296.008.046 19%
2013 592.866.349 50.07%
2014 576.456.969 -2.85%
2015 494.057.843 -16.68%
2016 513.170.006 3.72%
2017 619.905.000 17.22%
2018 698.832.000 11.29%
2019 728.406.000 4.06%
2020 675.995.000 -7.75%
2021 541.819.000 -24.76%
2022 507.417.000 -6.78%
2023 1.130.570.000 55.12%

Chemfab Alkalis Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
227.47
Net Income per Share
12.6
Price to Earning Ratio
82.86x
Price To Sales Ratio
4.59x
POCF Ratio
45.22
PFCF Ratio
45.22
Price to Book Ratio
3.85
EV to Sales
4.58
EV Over EBITDA
30.85
EV to Operating CashFlow
45.08
EV to FreeCashFlow
45.08
Earnings Yield
0.01
FreeCashFlow Yield
0.02
Market Cap
14,91 Bil.
Enterprise Value
14,87 Bil.
Graham Number
277.36
Graham NetNet
-41.47

Income Statement Metrics

Net Income per Share
12.6
Income Quality
1.25
ROE
0.05
Return On Assets
0.04
Return On Capital Employed
0.06
Net Income per EBT
0.64
EBT Per Ebit
1.25
Ebit per Revenue
0.07
Effective Tax Rate
0.37

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.24
Operating Profit Margin
0.07
Pretax Profit Margin
0.09
Net Profit Margin
0.06

Dividends

Dividend Yield
0
Dividend Yield %
0.12
Payout Ratio
0
Dividend Per Share
1.25

Operating Metrics

Operating Cashflow per Share
23.1
Free CashFlow per Share
23.1
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.03
Return on Tangible Assets
0.04
Days Sales Outstanding
23.85
Days Payables Outstanding
40.16
Days of Inventory on Hand
23.59
Receivables Turnover
15.31
Payables Turnover
9.09
Inventory Turnover
15.47
Capex per Share
0

Balance Sheet

Cash per Share
20,97
Book Value per Share
271,26
Tangible Book Value per Share
271.22
Shareholders Equity per Share
271.26
Interest Debt per Share
14.33
Debt to Equity
0.05
Debt to Assets
0.04
Net Debt to EBITDA
-0.09
Current Ratio
1.09
Tangible Asset Value
3,87 Bil.
Net Current Asset Value
-0,12 Bil.
Invested Capital
3292506000
Working Capital
0,09 Bil.
Intangibles to Total Assets
0
Average Receivables
0,11 Bil.
Average Payables
0,14 Bil.
Average Inventory
80073000
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Chemfab Alkalis Limited Dividends
Year Dividends Growth
2018 1
2019 1 0%
2020 1 0%
2022 1 0%
2023 1 0%
2024 1 0%

Chemfab Alkalis Limited Profile

About Chemfab Alkalis Limited

Chemfab Alkalis Limited manufactures and sells inorganic chemicals in India and internationally. It operates through Chemicals and Related Products/Services, and PVC-O Pipes segments. It offers caustic soda lye and flakes, liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite/bleach liquor products, as well as industrial grade and edible salt products. The company was formerly known as Teamec Chlorates Limited and changed its name to Chemfab Alkalis Limited in July 2017. Chemfab Alkalis Limited was founded in 1985 and is based in Chennai, India.

CEO
Mr. Vaithamanithi Mudumbai Sri
Employee
210
Address
TEAM House
Chennai, 600048

Chemfab Alkalis Limited Executives & BODs

Chemfab Alkalis Limited Executives & BODs
# Name Age
1 Mr. Suresh Krishnamurthi Rao
Founder & Non – Independent Non Executive Chairman
70
2 Mr. Vaithamanithi Mudumbai Srinivasan
Chief Executive Officer
70
3 Mr. S. Prasath
Chief Financial Officer
70
4 Mr. B. Vignesh Ram
Company Secretary, Compliance Officer & Nodal Officer
70
5 Mr. V. R. Raguraman
Vice President of Administration
70

Chemfab Alkalis Limited Competitors

Chembond Chemicals Limited Logo
Chembond Chemicals Limited

CHEMBOND.NS

(2.2)
AksharChem (India) Limited Logo
AksharChem (India) Limited

AKSHARCHEM.NS

(1.8)
Vinyl Chemicals (India) Limited Logo
Vinyl Chemicals (India) Limited

VINYLINDIA.NS

(3.2)
Bhageria Industries Limited Logo
Bhageria Industries Limited

BHAGERIA.NS

(2.0)